pembrolizumab
merck
['melanoma', 'pembro']
neoadjuvant versus adjuvant pembrolizumab for resectable stage ill-|v melanoma ( s1801) by dr. sapna patel significant 2 years efs with neoadjuvat approach in all subgroups #esmo22 
Pursuing to improve cancer prevention and care. Medical Oncologist @AnkaraUni